The role of brain-derived neurotrophic factor in the pathophysiology of adolescent suicidal behavior

International Journal of Adolescent Medicine and Health

Volumn 23, Issue 3, 2011, Pages 181-185

  Sher, Leo ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

adolescence; brain derived neurotrophic factor; serotonin; suicide

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; SEROTONIN;

ADOLESCENT DISEASE; BRAIN DEVELOPMENT; CHILD BEHAVIOR; DISEASE ASSOCIATION; HUMAN; MAJOR DEPRESSION; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PROTEIN FUNCTION; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT DEVELOPMENT; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; MENTAL DISORDERS; RISK FACTORS; SEROTONIN; SUICIDE;

EID: 80052778509     PISSN: 03340139     EISSN: 21910278     Source Type: Journal    
DOI: 10.1515/IJAMH.2011.041     Document Type: Review

References (49)

1. Bursztein C, Apter A. Adolescent suicide. Curr Opin Psychiatry 2009;22:1-6.
2. National Institute of Mental Health. Suicide in the U.S.: Statistics and prevention. Available at: Http://www.nimh.nih.gov/health/ publications/suicide- in-the-us-statistics-and-prevention/index. shtml. Accessed November 2, 2010.
3. American Foundation for Suicide Prevention. Fact and figures: International statistics. Available at: Http://www.afsp.org/index.cfm? fuseaction=home.viewpage&page-id=0512CA68-B182-FBB3-2E4CB905983C0AB8. Accessed November 2, 2010.
4. Sher L. Preventing suicide. QJM 2004;97:677-80.
5. World Health Organization. Mental health and substance abuse. Facts and figures. Suicide prevention. Available at: Http://www. searo.who.int/en/ section1174/section1199/section1567-6745. htm. Accessed November 1, 2010.
6. Berman AL, Jobes DA. Suicide prevention in adolescents (age 12-18). Suicide Life Threat Behav 1995;25:143-54.
7. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819-28.
8. Sher L, Oquendo MA, Mann JJ. Risk of suicide in mood disorders. Clin Neurosci Res 2001;1:337-44.
9. Carballo JJ, Oquendo MA, Giner L, Zalsman G, Roche AM, et al. Impulsive-aggressive traits and suicidal adolescents and young adults with alcoholism. Int J Adolesc Med Health 2006;18:15-9.
10. Sher L, Mann JJ. Neurobiology of suicide. In: Soares JC, Gershon S, editors. Textbook of medical psychiatry. New York: Marcel Dekker, 2003:701-11.
11. Rutter PA, Behrendt AE. Adolescent suicide risk: Four psychosocial factors. Adolescence 2004;39:295-302.
12. Brent DA, Baugher M, Bridge J. Age- and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry 1999;38:1497-505.
13. Dwivedi Y. Brain-derived neurotrophic factor: Role in depression and suicide. Neuropsychiatr Dis Treat 2009;5:433-49.
14. Dwivedi Y. Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 2010;42:87-96.
15. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006;361:1545-64.
16. Pardon MC. Role of neurotrophic factors in behavioral processes: Implications for the treatment of psychiatric and neurodegenerative disorders. Vitam Horm 2010;82:185-200.
17. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-69.
18. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-53.
19. Goldman-Rakic PS, Brown RM. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Brain Res 1982;256:339-49.
20. Rosenberg DR, Lewis DA. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol 1995;358:383-400.
21. Casey BJ, Giedd JN, Thomas KM. Structural and functional brain development and its relation to cognitive development. Biol Psychol 2000;54:241-57.
22. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995;15:7929-39.
23. Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res 2005;53:129-39.
24. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006;9:519-25.
25. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, et al. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res 2004;1025:10-20.
26. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry 2008;64:527-32.
27. Thomas MJ, Kalivas PW, Shaham Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 2008;154:327-42.
28. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: Role in pathogenesis and treatment. Behav Pharmacol 2010;21:427-37.
29. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000;48:721-31.
30. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15:1768-77.
31. Dell'osso L, Carmassi C, Del Debbio A, Dell'osso MC, Bianchi C, et al. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009;33: 899-902.
32. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002;22:3251-61.
33. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions. Psychiatry Clin Neurosci 2010;64:341-57.
34. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804-15.
35. TadićA, Wagner S, Schlicht KF, Peetz D, Borysenko L, et al. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:415-20.
36. Castrén E, Rantamäki T. Role of brain-derived neurotrophic factor in the aetiology of depression: Implications for pharmacological treatment. CNS Drugs 2010;24:1-7.
37. Griesbach GS, Hovda DA, Molteni R, Wu A, Gomez-Pinilla F. Voluntary exercise following traumatic brain injury: Brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 2004;125:129-39.
38. Vargas-Perez H, Ting-A Kee R, Walton CH, Hansen DM, Razavi R, et al. Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science 2009;324:1732-4.
39. Logrip ML, Janak PH, Ron D. Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J Neurochem 2009;109:1459-68.
40. Kim YK, Lee HP, Won SD, Park EY, Lee HY, et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:78-85.
41. Lee BH, Kim YK. BDNF mRNA expression of peripheral blood mononuclear cells was decreased in depressive patients who had or had not recently attempted suicide. J Affect Disord 2010;125:369-73.
42. Kimata H. Differential modulation of cerebrospinal fl uid neurotrophins in patients with atopic dermatitis who attempted suicide. J Clin Psychiatry 2005;66:1193-4.
43. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005;136:29-37.
44. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010;67:258-67.
45. Pregelj P, Nedic G, Paska AV, Zupanc T, Nikolac M, et al. The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. J Affect Disord 2011;128:287-90.
46. Kim B, Kim CY, Hong JP, Kim SY, Lee C, et al. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 2008;582:97-103.
47. Zetterstrom TS, Pei Q, Madhav TR, Coppell AL, Lewis L, et al. Manipulations of brain 5HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 1999;38:1063-73.
48. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27:589-94.
49. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, et al. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008;55:1006-14.